Quagen Company Profile
✉ Email this page to a colleague
What is the competitive landscape for QUAGEN, and what generic and branded alternatives to QUAGEN drugs are available?
QUAGEN has twenty-five approved drugs.
Drugs and US Patents for Quagen
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Quagen | LEVETIRACETAM | levetiracetam | SOLUTION;ORAL | 090079-001 | Apr 11, 2012 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Quagen | LIDOCAINE | lidocaine | OINTMENT;TOPICAL | 212695-001 | Apr 20, 2021 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Quagen | FLUOCINOLONE ACETONIDE | fluocinolone acetonide | OIL/DROPS;OTIC | 212762-001 | Apr 2, 2021 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Quagen | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | SOLUTION;ORAL | 213567-002 | Jun 4, 2020 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Quagen | ALBUTEROL SULFATE | albuterol sulfate | SYRUP;ORAL | 212197-001 | Sep 6, 2019 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Quagen | OXYCODONE HYDROCHLORIDE | oxycodone hydrochloride | SOLUTION;ORAL | 213761-001 | Jun 2, 2021 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Quagen | BUTALBITAL AND ACETAMINOPHEN | acetaminophen; butalbital | TABLET;ORAL | 214305-001 | Feb 1, 2024 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.